323 related articles for article (PubMed ID: 26248218)
1. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance.
Nuotio-Antar AM; Poungvarin N; Li M; Schupp M; Mohammad M; Gerard S; Zou F; Chan L
Endocrinology; 2015 Nov; 156(11):4020-32. PubMed ID: 26248218
[TBL] [Abstract][Full Text] [Related]
2. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
3. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
4. Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.
Jois T; Howard V; Youngs K; Cowley MA; Sleeman MW
PLoS One; 2016; 11(12):e0168797. PubMed ID: 27992582
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
6. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
Herman MA; Peroni OD; Villoria J; Schön MR; Abumrad NA; Blüher M; Klein S; Kahn BB
Nature; 2012 Apr; 484(7394):333-8. PubMed ID: 22466288
[TBL] [Abstract][Full Text] [Related]
7. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
8. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.
Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO
Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 gene transfer reverses body weight gain and fatty liver in obese mice.
Ma Y; Gao M; Sun H; Liu D
Biochim Biophys Acta; 2015 May; 1852(5):1001-11. PubMed ID: 25660446
[TBL] [Abstract][Full Text] [Related]
10. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
11. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
12. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice.
Mercader J; Ribot J; Murano I; Feddersen S; Cinti S; Madsen L; Kristiansen K; Bonet ML; Palou A
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E184-93. PubMed ID: 19417128
[TBL] [Abstract][Full Text] [Related]
13. Fat and carbohydrate in western diet contribute differently to hepatic lipid accumulation.
Wu W; Tsuchida H; Kato T; Niwa H; Horikawa Y; Takeda J; Iizuka K
Biochem Biophys Res Commun; 2015 Jun; 461(4):681-6. PubMed ID: 25931000
[TBL] [Abstract][Full Text] [Related]
14. Chronic hyperprolactinemia evoked by disruption of lactotrope dopamine D2 receptors impacts on liver and adipocyte genes related to glucose and insulin balance.
Luque GM; Lopez-Vicchi F; Ornstein AM; Brie B; De Winne C; Fiore E; Perez-Millan MI; Mazzolini G; Rubinstein M; Becu-Villalobos D
Am J Physiol Endocrinol Metab; 2016 Dec; 311(6):E974-E988. PubMed ID: 27802964
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of IKKβ in adipose tissue prevents diet-induced obesity in mice.
Jiao P; Feng B; Ma J; Nie Y; Paul E; Li Y; Xu H
Endocrinology; 2012 Jan; 153(1):154-65. PubMed ID: 22067324
[TBL] [Abstract][Full Text] [Related]
16. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
17. Liquid fructose in Western-diet-fed mice impairs liver insulin signaling and causes cholesterol and triglyceride loading without changing calorie intake and body weight.
Baena M; Sangüesa G; Hutter N; Beltrán JM; Sánchez RM; Roglans N; Alegret M; Laguna JC
J Nutr Biochem; 2017 Feb; 40():105-115. PubMed ID: 27883935
[TBL] [Abstract][Full Text] [Related]
18. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.
Darkhal P; Gao M; Ma Y; Liu D
Int J Obes (Lond); 2015 Aug; 39(8):1292-9. PubMed ID: 25869601
[TBL] [Abstract][Full Text] [Related]
19. Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop.
Jing G; Chen J; Xu G; Shalev A
Mol Metab; 2016 Dec; 5(12):1208-1215. PubMed ID: 27900263
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver.
Kim K; Kang JK; Jung YH; Lee SB; Rametta R; Dongiovanni P; Valenti L; Pajvani UB
Nat Commun; 2021 Mar; 12(1):1822. PubMed ID: 33758172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
